A review and analysis of registry data from patients with RA indicates that changing from rituximab to another class of biologic agent does not alter the subsequent risk of infection.
An international EULAR taskforce has derived a set of clinical parameters to aid in identifying patients who may have CSA.
The network meta-analysis found no clinically meaningful differences for achieving RA disease remission with biologic monotherapy versus active comparator.
Study examines the relationship between bone marrow edema and neck pain in patients with rheumatoid arthritis and ankylosing spondylitis.
New research validates use of statistically based individual improvements to track changes in rheumatoid arthriits outcomes during adalimumab therapy.
Temporary discontinuation of methotrexate appears to improve the immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis.
Sports medicine experts, emergency medicine physicians, and orthopedic surgeons are reporting that their experiences with cervical spine instability related to rheumatoid arthritis are evolving.
Researchers performed a retrospective analysis of 3 cohorts of women with prior history breast cancer and rheumatoid arthritis or inflammatory bowel disease to determine the risk of breast cancer recurrence with methotrexate, anti-TNF inhibitors, and thiopurines.
The accurate assessment of disease activity in rheumatoid arthritis (RA) is necessary to facilitate adequate suppression of inflammation in order to limit the progression of joint and periarticular damage
Antibody concentrations against antigen epitopes of the oral pathogen P gingivalis appear to increase prior to the onset of RA symptoms, suggesting that P gingivalis may be associated with RA pathogenesis.
